News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Hagen Kennecke: First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer
Photo of Hagen Kennecke from ohsu.edu
Jul 10, 2024, 15:30

Hagen Kennecke: First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer

Hagen Kennecke, Section chief and Chief Health Officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared a post on X:

”First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer, OS HR=0.4.

Patients are asking: do we recommend COX-2 for the 20% with mutation PIK3CA? 

Need to do NGS for all stage III CRC.”

Source: Hagen Kennecke/X

Anthony F Shields Ardaman Shergill Benjamin Tan cancer Chao Ma Charles S Fuchs Colon cancer Eileen M. O'Reilly Felix Couture Hagen Kennecke James Knight Jeffrey A Meyerhardt Jonathan A Nowak Juha Väyrynen Kenji Fujiyoshi Koichiro Haruki Melissa Zhao OncoDaily Oncology Pankaj Kumar Philip Kuebler Philip Philip Qian Shi Shrikant Mane Shuji Ogino Smitha Krishnamurthi Tyler Twombly
Special Coverage
Opinion
Nov 13, 2024, 23:52
Growing the pipeline of talented Black researchers in cancer - President's Cancer Panel
Opinion
Nov 13, 2024, 23:48
Why pursue a career in psycho-oncology? New speaker: Linda Carlson - IPOS
Opinion
Nov 13, 2024, 23:46
Oliver Bogler: InFUSE's first talk by Domenico D'Atri
Opinion
Nov 13, 2024, 23:44
Peter Pisters: Honoring the veterans and active service members who have served our nation
Opinion
Nov 13, 2024, 23:39
Ajay Major: New consensus algorithm for the treatment of NLPHL by Graham Collins and Chan Cheah
Insight
Nov 13, 2024, 23:35
Raffaele Colombo: New BLA submitted for patients with EGFR-m NSCLC
Insight
Nov 13, 2024, 23:33
Closing the gap in lung cancer care - Color
Insight
Nov 13, 2024, 23:31
Researchers at the ICR have identified a promising treatment target for Acute Myeloid Leukaemia
Insight
Nov 13, 2024, 23:28
Danielle Bitterman: Looking forward to EMNLP2024
Insight
Nov 13, 2024, 23:26
Efficacy of subsequent therapies in advanced ovarian cancer
Insight
Nov 13, 2024, 23:24
Toufic Kachaamy: The yearly Phoenix walk to raise awareness for colorectal cancer
Insight
Nov 13, 2024, 23:22
Mireia Crispin on the emerging fields of application of AI tools